ZOMDF
Zomedica Corp.
$0.10+0.00 (0.00%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Zomedica Pharmaceuticals Corp. (ZOM) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 25 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-18 | 2025-11-17 | Cohen Robert | Director | Award | 1,823,107 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Macleod Christopher Ross | Director | Award | 1,823,107 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Whelan Sean | Director | Award | 1,975,033 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Williams Rodney James | Director | Award | 1,975,033 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Rowe Jeffrey M | Director | Award | 2,126,959 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Nichols Pamela | Director | Award | 1,823,107 | $0.00 | $0 | N/A | N/A |
| 2025-11-18 | 2025-11-17 | Powers Johnny D | Director | Award | 1,823,107 | $0.00 | $0 | N/A | N/A |
| 2025-11-14 | 2025-11-13 | Klass Russell Kevin | VP | Purchase | 150,000 | $0.10 | $14,550 | +13.4% | +13.4% |
| 2025-11-12 | 2025-11-10 | Klass Russell Kevin | VP | Purchase | 120,000 | $0.10 | $11,760 | -8.2% | +12.2% |
| 2025-11-10 | 2025-11-07 | Klass Russell Kevin | VP | Purchase | 5,000 | $0.10 | $475 | +5.3% | +15.8% |
ZOMDF
Director
Award
$0
Macleod Christopher Ross1,823,107 shares @ $0.00
Filed 2025-11-18Trade 2025-11-17
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.